Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanostart AG Commences U.S. Trading of ADRs

Abstract:
Nanostart AG (fwb:NNS), the Frankfurt-based nanotechnology investment company, announced the commencement of trading today of its American Depositary Receipts (ADRs), which will now trade in the United States on the OTCQX electronic trading system under the ticker symbol NASRY.

Nanostart AG Commences U.S. Trading of ADRs

Frankfort, Germany | Posted on October 21st, 2010

With this step, Nanostart ADRs can now be traded on the world's largest capital market, the United States, like any other U.S. security: during U.S. market hours, with pricing and settlement in U.S. dollars, and with normal custody in U.S. brokerage accounts.

ADRs are securities issued by a U.S. depositary bank which certify ownership of the shares of an international company held in safekeeping by the bank. Because they are U.S. domestic securities, ADRs are a convenient alternative to direct ownership of foreign equities. The depositary bank for the ADRs of Nanostart AG, which is a Sponsored Level 1 program, is Bank of New York Mellon. Ten Nanostart ADRs correspond to one Nanostart share.

"The admission of our ADRs for trading on the OTCQX offers many of the benefits of a full U.S. exchange listing, but without the associated high costs and legal burden," explained Marco Beckmann, CEO of Nanostart AG. "Through the ADR program, U.S. investors gain access to foreign equities through the domestic U.S. market system. The U.S. capital market opens a whole new dimension for international companies."

"Companies use OTCQX to expand their access to investors, engage them with quality disclosure of their financials, and provide trading transparency to stimulate liquidity," said R. Cromwell Coulson, President and CEO of Pink OTC Markets Inc., parent of the trading system. "We are pleased to welcome Nanostart to OTCQX."

The ADR program does not constitute an offering of shares by Nanostart AG, nor may these ADRs be offered publicly in Germany. Investors may obtain real-time financial and trading information about Nanostart ADRs under www.otcqx.com as well as www.otcmarkets.com.

Disclaimer:

This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the "Entry Standard" segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within Canada, Australia or Japan.

####

About Nanostart
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world's leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government. Some U.S. peer companies which are likewise engaged in nanotechnology or other high-tech investing are Harris & Harris Group Inc. (TINY 4.29, +0.03, +0.70%), Arrowhead Research Corp. (ARWR 0.10, +0.03, +2.99%) and Safeguard Scientifics Inc. (SFE 13.74, +0.25, +1.85%).

For further information about the company, please visit www.nanostart.de.

About OTCQX
The OTCQX marketplace is the premier tier of the U.S. OTC market. Investor-focused companies use the quality-controlled OTCQX platform to offer investors transparent trading, superior information, and easy access through their regulated U.S. broker-dealers. The innovative OTCQX platform offers companies and their shareholders a level of marketplace services formerly available only on a U.S. stock exchange. For more information and to view a full list of OTCQX companies, visit www.otcqx.com.

About Pink OTC Markets
Pink OTC Markets Inc. (otcqx:PINK) operates the leading electronic interdealer quotation and trading system for over 9,000 securities not listed on a U.S. stock exchange. Pink OTC Markets segments these securities into three tiers: the quality-controlled OTCQX marketplace, the U.S. registered and reporting OTCQB marketplace, and the speculative trading Pink Sheetsmarketplace. These three tiers constitute the third largest U.S. liquidity pool for trading public company shares, after The NASDAQ Stock Market, Inc. and The New York Stock Exchange. The products and services promote market transparency, improve price discovery, facilitate regulatory compliance, and increase the quality of issuer disclosure, to the benefit of all OTC market participants. To learn more about how Pink OTC Markets' products and services make OTC markets more transparent, informed, and efficient, please visit the websites at www.otcmarkets.com, www.pinkotc.com and www.otcqx.com or contact us at

For more information, please click here

Contacts:
Nanostart AG
Public Relations
Dr. Hans Joachim Durr
phone: +49 69-21 93 96 111
fax: +49 69-21 93 96 122

Copyright © Nanostart

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project